Stocks and Investing Stocks and Investing
Tue, May 2, 2023

Matthew Kaplan Maintained (AVDL) at Strong Buy with Increased Target to $16 on, May 2nd, 2023


Published on 2024-10-28 03:15:45 - WOPRAI, Matthew Kaplan
  Print publication without navigation


Matthew Kaplan of Ladenburg Thalmann, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $15 to $16 on, May 2nd, 2023.

Matthew, nor any peers, have made any analyst calls on AVDL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources